Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review
Advances in Mental Health July 13, 2023 Jorge Valdiviezo‐oña, Lizbeth Toscano-Molina, Juan Fernando Chávez et al. 4 citations
A systematic review of six studies found that people with eating disorders who used psychedelics (ayahuasca, DMT, LSD, mescaline, psilocybin, or ketamine) in clinical or non-clinical settings often reported reduced eating disorder symptoms, anxiety, self-harm, suicidality, and problematic substance use, along with improvements in depression and well-being. Some achieved complete remission. Participants described profound spiritual healing and insights into the psychological roots of their disorder. All qualitative studies met full quality criteria, while quantitative studies scored 20% to 60%. The findings are preliminary; randomized controlled trials are needed to confirm efficacy and long-term effects.